Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Basis of preparation (Tables)

v3.26.1
Basis of preparation (Tables)
 12 Months Ended
Dec. 31, 2025
Basis of preparation.  
Schedule of company's subsidiary

​

​

​

​

​

​

​

Name

  ​ ​ ​

Place of Incorporation

  ​ ​ ​

Ownership

 

XORTX Pharma Corp.

 

Canada

 

100%

​